Cardiac Monitoring and Cardiac Rhythm Management Devices Market

Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size

The size of the global cardiac monitoring and cardiac rhythm management devices market was worth USD 27.10 billion in 2025. The global market is anticipated to grow at a CAGR of 7.5% from 2026 to 2034 and be worth USD 51.96 billion by 2034 from USD 29.13 billion in 2026.

MARKET DRIVERS

The growing prevalence and incidence of cardiovascular diseases are anticipated to drive the global cardiac monitoring and cardiac rhythm management devices market growth. Cardiovascular diseases are one of the leading causes of death. As per WHO, around 30 million people are affected by heart attacks and strokes every year. By 2035, over 130 million and above adults are predicted to have cardiovascular diseases. The growing life span and availability of technological advancements in treating cardiovascular devices are further driving the market growth.

In countries like Canada, the United States, and the U.K., patients are highly adopting cardiac rhythm management devices due to acceptable reimbursement policies, propelling the market. Growing government efforts, creating awareness, and adopting a sedentary lifestyle drive the cardiac monitoring and cardiac rhythm management devices market. Increasing healthcare expenses leading to the adoption of technology advancements and growing demand for telehealth products drives the market growth. Increasing adoption of monitoring devices in hospitals is likely to surge the growth rate of the market.

CIEDs are the devices used to improve patients' life expectancy and quality when treated with cardiac arrhythmias. This factor is creating growth opportunities for the cardiac monitoring and cardiac rhythm management devices market.

MARKET RESTRAINTS

Besides, some factors are restraining the growth of the cardiac monitoring and cardiac rhythm management devices market. They are a shortage of skilled professionals such as doctors and technicians with expertise in cardiac monitoring and uncertainty in cardiac monitoring devices' reimbursement policies. Furthermore, economic slowdown and disturbed reimbursement policies hinder the growth of the cardiac monitoring and cardiac rhythm management devices market growth. In addition, the dearth of trained professionals like doctors and technicians with experience monitoring cardiac diseases, heart rate, and ambiguity in cardiac monitoring devices hamper the market demand during the analysis period.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Insights

Based on the product, the ECG segment is forecasted to account for the largest share of the global cardiac monitoring and cardiac rhythm management devices market during the forecast period. The segment’s growth is mainly attributed to the growing requirements in patients suffering from strokes, heart attacks, and arrhythmias. Monitoring continuous growth rate increases ECG devices' usage surge the cardiac monitoring and cardiac rhythm management devices market growth.

By CRM Insights

Based on the CRM type, the external defibrillators segment is expected to have the highest CAGR growth rate in the cardiac monitoring and cardiac rhythm management devices market. The segment growth is driven by factors like advanced technologies in producing and manufacturing defibrillators, stimulating common cases of cardiovascular diseases, and rising consciousness in providing general public access to defibrillators.

The pacemaker segment is expected to hold the second-largest market share during the forecast period.

By End User Insights

Based on the end-user analysis, the hospital segment is predicted to have the highest market share during the analysis period. Factors like the surging number of patients visiting hospitals more frequently for diagnosis purposes and the rising number of implant procedures propel the cardiac monitoring and cardiac rhythm management devices market demand. The easy availability of reimbursement policies and procedures followed for cardiac implants is impelling the market growth.

REGIONAL ANALYSIS

By geography, the Asia-Pacific is relied upon to be the quickest developing cardiac monitoring and cardiac rhythm management devices market during the forecast period attributable to the expanding prevalence of cardiovascular diseases, rising interests in healthcare, expanding geriatric populace, and extensions by market players in the region. Asia-Pacific is giving a robust challenge in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market by creating financially savvy items highly sought after in nearby just as worldwide markets.

The European market is required to be the second-biggest Cardiac Monitoring and Cardiac Rhythm Management Devices Market. The market development in this area can be ascribed to government subsidizing and support of the healthcare sector, combined with expanding innovative work. Also, a developing number of surgeries because of the changing way of life add to the market's development in this region. The Middle East and African market is required to represent the littlest share in the Cardiac Monitoring and Cardiac Rhythm Management Devices Market because of the underdeveloped healthcare sector, absence of technical knowledge, and inadequate therapeutic facilities.

North America will command the worldwide Cardiac Monitoring and Cardiac Rhythm Management Devices Market over the estimated forecast period. The expanding investments by North America in cardiovascular gadgets in the most recent couple of years have prompted the market's development in this area. The expanding number of heart patients, better healthcare infrastructure, and cutting-edge innovation in cardiovascular monitoring equipment have helped the cardiac monitoring and cardiac rhythm management device market in North America.

KEY MARKET PLAYERS

The notable market participants dominating the global cardiac monitoring and cardiac rhythm management devices market are

• Medtronic plc
• Abiomed, Inc.
• Abbott Laboratories
• Berlin Heart
• Boston Scientific Corporation
• Cardiac Science Corporation
• BIOTRONIK AG
• Hill-Rom Services, Inc.
• GE Healthcare
• Jarvik Heart, Inc.
• Philips Healthcare
• Koninklijke Philips N.V.
• Nihon Kohden Corporation
• ReliantHeart, Inc.
• SCHILLER AG

The business unit CRM of BIOTRONIK comprises leads, implantable devices and accessories, external devices, and treatment and management of arrhythmia-related diseases. Mainly designed implantable devices for either too slow or too fast a rhythm help patients benefit as their overall health status can be gained. Essential innovative treatment options of BIOTRONIK CRM such as BIOTRONIK Home Monitoring, ProMRI, i.e., the DX technology, MR conditional devices, Closed-Loop-Stimulation as a highly superior system to physiologically regulate the cardiac activity, and fractal coating line the path of innovative milestones of BIOTRONIK.

MARKET SEGMENTATION

This global cardiac monitoring and cardiac rhythm management devices market research report is segmented and sub-segmented into the following categories.

By Product

• ECG
• Cardiac Output Monitoring
• ILR

By CRM

• ICDs
• External Defibrillator
• Pacemaker

By End User

• Home and Ambulatory
• Hospitals

By Region

• North America
• Europe
• Asia-Pacific
• Middle East Africa
• Latin America